La patentabilidad de invenciones biotecnológicas y sobre la medicina de precisión: protección jurídica de las invenciones sobre genética, biomarcadores, tests diagnósticos y algoritmos para la medicina personalizada como materia susceptible de patente
Year: 2020
Type: dissertation
Abstract: [EN]The overall goal of this doctoral thesis/dissertations (SJD) is 1) to examine the impact of three seminal international cases Myriad, Mayo, and Alice) by developing evidence-based (empirical) IP studies designed to understand the effect of these decisions at various levels of analysis, and 2) to conduct a comparative legal analysis across developed jurisdictions (US and Europe) on the patentability of information age inventions affecting precision medicine (biotech and computer-related inventions). These evidence-based IP studies include three levels of analysis: - Broad-level impact analysis (before & after patent landscape effects) - Claim-level impact analysis (before & after claims, claim scope, claim strategies, claim formulations) - Prosecution-level analysis (before & after prosecution timelines, prosecutions strategies, effects on different types of entities). The results of these three level of analysis are also the basis of "wide-impact studies'' designed to understand the side effects, ripple effects, and unexpected consequences of legal, regulatory, or examination guidance changes. In summary, the fundamental aim of this doctoral thesis/dissertation is to conduct an in-depth legal analysis of key US Supreme Court decisions affecting biotech (Myriad and Mayo) and computer implemented inventions (Alice), as well as the corresponding European patent law in order to: - better understand the legal impact of these decisions across both sides of the Atlantic; - report the results of evidence-based studies aimed at analyzing the impact and effect of these seminal decisions; - offer empirical evidence to on-going legal debates about the significance of these cases on the changing landscape of patents claiming 1) nucleic acids, 2) nature-based products, 3) biomarkers, 4) medical correlations and relationships, and 4) algorithms, AI and big data techniques; and - compare the patent law jurisprudence and examine the degree of convergence/divergence with regards to substantive patent law between US and EPC signatory jurisdictions for information age inventions affecting the emerging field of precision medicine (biotech and computer-related).
Source: Gredos (University of Salamanca)
Author: Riobo Aboy, Pedro Mateo
Language: English
Topic: Intellectual Property Law
Subfield: Law
Field: Social Sciences
Domain: Social Sciences
Keywords: patentability, biotechnological inventions, precision medicine, personalized medicine, United States Supreme Court, European patent law, EPC, computer-implemented inventions, algorithms, artificial intelligence, big data, biomarkers, diagnostic testing, nucleic acids, nature-based products, patent claim drafting, patent prosecution, comparative patent law, United States and Europe
Open Access status: green
Funders: Harvard University, Novo Nordisk
Award: G8491405732
OpenAlex ID: W7057595291
